Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
Ya WangLong QiaoJie YangXiong LiYaqi DuanJiahao LiuShaoqi ChenHuayi LiDan LiuTian FangJingjing MaXiaoting LiFei YeJunxiang WanJuncheng WeiQin XuEnsong GuoPing JinMingfu WuLin ZhangYun XiaYaqun WuJun ShaoYaojun FengQing ZhangZongyuan YangGang ChenQinghua ZhangXingrui LiShixuan WangJunbo HuXiaoyun WangMona P TanKazuaki TakabeBeihua KongQifeng YangDing MaQing-Lei GaoPublished in: Cancer communications (London, England) (2021)
Serum SEMA4C demonstrated promising potential as a candidate biomarker for breast cancer diagnosis. However, validation in prospective settings and by other study groups is warranted.